The severe acute respiratory syndrome (SARS) coronavirus NTPase/helicase belongs to a distinct class of 5' to 3' viral helicases.

The Journal of Biological Chemistry
Julian A TannerJian-Dong Huang


The putative NTPase/helicase protein from severe acute respiratory syndrome coronavirus (SARS-CoV) is postulated to play a number of crucial roles in the viral life cycle, making it an attractive target for anti-SARS therapy. We have cloned, expressed, and purified this protein as an N-terminal hexahistidine fusion in Escherichia coli and have characterized its helicase and NTPase activities. The enzyme unwinds double-stranded DNA, dependent on the presence of a 5' single-stranded overhang, indicating a 5'o 3' polarity of activity, a distinct characteristic of coronaviridae helicases. We provide the first quantitative analysis of the polynucleic acid binding and NTPase activities of a Nidovirus helicase, using a high throughput phosphate release assay that will be readily adaptable to the future testing of helicase inhibitors. All eight common NTPs and dNTPs were hydrolyzed by the SARS helicase in a magnesium-dependent reaction, stimulated by the presence of either single-stranded DNA or RNA. The enzyme exhibited a preference for ATP, dATP, and dCTP over the other NTP/dNTP substrates. Homopolynucleotides significantly stimulated the ATPase activity (15-25-fold) with the notable exception of poly(G) and poly(dG), which were non-...Continue Reading


Apr 1, 1997·Journal of Virology·G Kadaré, A L Haenni
Apr 1, 1997·Virus Research·R Buckland, T F Wild
Jun 1, 1997·Nature Structural Biology·N YaoP C Weber
Mar 22, 2000·The Journal of General Virology·J ZiebuhrA E Gorbalenya
Feb 17, 2001·Current Opinion in Structural Biology·J H LaityP E Wright
Feb 13, 2002·Current Opinion in Structural Biology·Jonathan M Caruthers, David B McKay
Apr 3, 2002·Nature Medicine·James J CruteMichael G Cordingley
Apr 3, 2002·Nature Medicine·Gerald KleymannHelga Rübsamen-Waigmann
Sep 11, 2002·Antiviral Research·Peter BorowskiHerbert Schmitz
Jan 31, 2003·Expert Opinion on Investigational Drugs·Gerald Kleymann
Apr 12, 2003·The New England Journal of Medicine·Christian DrostenHans Wilhelm Doerr
Apr 12, 2003·The New England Journal of Medicine·Thomas G KsiazekUNKNOWN SARS Working Group
Apr 25, 2003·Lancet·J S M PeirisUNKNOWN SARS study group
May 6, 2003·Science·Marco A MarraRachel L Roper
Jun 5, 2003·The Journal of Clinical Investigation·Kathryn V Holmes
Aug 15, 2003·The Journal of General Virology·Volker ThielJohn Ziebuhr

❮ Previous
Next ❯


Mar 8, 2005·Drug Discovery Today·Yossef KligerDoron Gerber
Sep 17, 2004·Nature Reviews. Microbiology·Erik De Clercq
Oct 25, 2007·Chemical Communications : Chem Comm·Nan YangHongzhe Sun
Aug 7, 2010·The Journal of Biological Chemistry·Seung-Joo Lee, Charles C Richardson
Nov 17, 2005·Journal of Neurovirology·Samson S Y Wong, K Y Yuen
May 7, 2004·European Journal of Biochemistry·Narendra Tuteja, Renu Tuteja
Jan 15, 2010·Journal of Virology·Yogesh A Karpe, Kavita S Lole
May 23, 2012·PloS One·Adeyemi O AdedejiStefan G Sarafianos
Dec 4, 2012·Viruses·Marne C HagemeijerCornelis A M de Haan
Feb 6, 2016·Virologica Sinica·Yu Chen, Deyin Guo
Jul 15, 2015·Proceedings of the National Academy of Sciences of the United States of America·Yuanyuan MaZihe Rao
Feb 11, 2012·Current Opinion in Chemical Biology·Hongyan Li, Hongzhe Sun
Feb 15, 2005·Antiviral Research·Yee-Joo TanWanjin Hong
Sep 11, 2004·Current Opinion in Microbiology·John Ziebuhr
Mar 1, 2006·Virus Research·Alexander E GorbalenyaEric J Snijder
Nov 29, 2005·Virus Research·Ian Brierley, Francisco J Dos Ramos
Dec 17, 2014·Virus Research·Kathleen C LehmannAlexander E Gorbalenya
Sep 1, 2012·Biochemical Pharmacology·Young-Sam Keum, Yong-Joo Jeong
Aug 3, 2013·Expert Opinion on Therapeutic Patents·Vathan KumarPo-Huang Liang
Dec 18, 2007·Biochemical and Biophysical Research Communications·Kyoung Jin JangDong-Eun Kim
Aug 21, 2007·Virology·Jianqiang ZhangUdeni B R Balasuriya
Dec 21, 2013·Virus Research·Benjamin W NeumanJeremiah Joseph
Dec 3, 2014·Virus Research·Marion SevajolIsabelle Imbert
Mar 24, 2016·FEBS Letters·Ambily Abraham, Handanahal S Savithri
Mar 10, 2016·Annual Review of Virology·Isabel SolaLuis Enjuanes
Mar 3, 2005·Antiviral Chemistry & Chemotherapy·John S OxfordRobert Lambkin
Nov 30, 2013·Pharmaceuticals·Ka-To ShumJohn J Rossi
Jul 25, 2007·Angewandte Chemie·Nan YangJian-Dong Huang
Nov 26, 2008·Chembiochem : a European Journal of Chemical Biology·Ka To Shum, Julian A Tanner
Sep 8, 2010·Angewandte Chemie·Hongje JangDal-Hee Min
Apr 7, 2006·Expert Review of Anti-infective Therapy·Erik De Clercq
May 16, 2009·Expert Opinion on Therapeutic Patents·Tommy R Tong

❮ Previous
Next ❯

Software Mentioned


Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.